Revance Therapeutics Inc (RVNC)
4.17
-0.14
(-3.25%)
USD |
NASDAQ |
Nov 15, 16:00
4.175
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Shares Outstanding: 104.90M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 104.90M |
September 30, 2024 | 104.90M |
August 08, 2024 | 104.18M |
July 31, 2024 | 104.82M |
June 30, 2024 | 104.81M |
April 30, 2024 | 104.45M |
March 31, 2024 | 104.41M |
March 08, 2024 | 104.22M |
March 06, 2024 | 104.21M |
February 16, 2024 | 88.21M |
December 31, 2023 | 87.96M |
October 31, 2023 | 87.81M |
September 30, 2023 | 87.81M |
July 31, 2023 | 87.96M |
June 30, 2023 | 87.95M |
April 28, 2023 | 84.04M |
March 31, 2023 | 84.02M |
March 10, 2023 | 83.85M |
February 16, 2023 | 82.80M |
December 31, 2022 | 82.39M |
October 31, 2022 | 82.27M |
September 30, 2022 | 82.29M |
September 15, 2022 | 82.31M |
July 29, 2022 | 73.11M |
June 30, 2022 | 73.12M |
Date | Value |
---|---|
April 29, 2022 | 72.77M |
March 31, 2022 | 71.76M |
March 11, 2022 | 71.43M |
February 17, 2022 | 71.45M |
December 31, 2021 | 71.58M |
October 28, 2021 | 71.79M |
September 30, 2021 | 71.84M |
July 28, 2021 | 71.83M |
June 30, 2021 | 71.80M |
April 27, 2021 | 71.53M |
March 31, 2021 | 71.41M |
March 11, 2021 | 71.38M |
February 28, 2021 | 71.41M |
February 22, 2021 | 69.85M |
February 12, 2021 | 71.38M |
December 31, 2020 | 69.18M |
October 30, 2020 | 66.55M |
September 30, 2020 | 66.59M |
July 24, 2020 | 65.93M |
July 23, 2020 | 65.78M |
June 30, 2020 | 57.31M |
June 18, 2020 | 57.21M |
June 01, 2020 | 57.18M |
May 31, 2020 | 57.15M |
May 15, 2020 | 57.12M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
52.37M
Minimum
Dec 31 2019
104.90M
Maximum
Oct 31 2024
76.13M
Average
71.80M
Median
Shares Outstanding Benchmarks
Recursion Pharmaceuticals Inc | 286.64M |
Regeneron Pharmaceuticals Inc | 109.89M |
MEI Pharma Inc | 6.663M |
GlycoMimetics Inc | 64.48M |
Anebulo Pharmaceuticals Inc | 25.93M |